Perspectives from CPhI Worldwide - Jan-Olav Henck

Nov 08, 2011
By PharmTech Editors

Jan-Olav Henck


Jan-Olav Henck, PhD,
chief scientific officer
Aptuit


Add this Podcast feed to your media player


Jan-Olav Henck, PhD, chief scientific officer at Aptuit, discusses strategies and considerations in polymorph screening with Patricia Van Arnum, senior editor of Pharmaceutical Technology (Posted November 2011).